期刊文献+

试从中医"疫毒夹湿"探讨新型冠状病毒肺炎(COVID-19)防治思路 被引量:21

To Explore the Prevention and Treatment of COVID-19 based on "Yidujiashi" theory
原文传递
导出
摘要 目的:探讨新型冠状病毒肺炎(COVID-19)的中医防治方法,为从"疫毒夹湿"角度治疗新型冠状病毒肺炎提供临床理论依据。方法:通过分析武汉地域气候特点,结合武汉红十字医院病例发病规律,查阅"疫病"相关文献,总结归纳中医防治新型冠状病毒肺炎的思路。结果:传统医学认为该病归属于中医"疫病"范畴,病机为疫毒袭肺,肺失宣降,邪热夹湿耗伤气阴。病位主要在肺,或兼在脾胃。治疗上可分期论治,注重宣降肺气,兼顾脾胃,同时养阴益气。通过养正辟邪等措施可以达到预防目的。结论:"疫毒夹湿"理论为中医治疗新型冠状病毒肺炎提供了新的思路,能够有效指导临床治疗的选方用药,但因病例和地域的局限性,需要进一步拓展思路与方法。 Objective: To explore a new type of prevention and treatment of COVID-19 with traditional Chinese medicine based on "Yidujiashi" theory, and provide a clinical theoretical basis. Methods: By analyzing the regional climate characteristics in Wuhan, combined with the pathogenic patterns of cases in Wuhan Red Cross Hospital, referring to the relevant literature of "epidemic disease", we summarized the idea of prevention and treatment of COVID-19 with traditional Chinese medicine. Results: In traditional Chinese medicine, this disease was classified as "epidemic disease" in traditional Chinese medicine, the pathogenesis of the disease is "Yiduxifei", "Feishixuanjiang" and "Xierejiashi, Haoshangqiyin". The disease mainly affected lung, as well as the spleen and stomach. In different clinical stages, different remedies were applied which focused on "Xuanjiangfeiqi" and "Yangyinyiqi", took into account the treatment of spleen and stomach. In preventive stage, "Yangzhengbixie" was often applied. Conclusion: The theory of "Yidujiashi" provides a new idea for the treatment of COVID-19 with Traditional Chinese medicine, it can effectively guide the choice of prescription for clinical treatment. However, further exploration should be done on new methods and ideas because of the limitations of cases and regions.
作者 杨洋 高培阳 黄青松 唐健元 谢春光 由凤鸣 张传涛 杨洪静 肖玮 孙增涛 张宏 Yang Yang;Gao Peiyang;Huang qingsong;Tang Jianyuan;Xie Chunguang;You Fengming;Zhang Chuantao;Yang Hongjing;Xiao Wei;Sun Zengtao;Zhang Hong(Chengdu University of Traditional Chinese Medicine,Chengdu 610072;Department of Critical Care Medicine,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072;Respiratory department,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072;Teaching Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072)
出处 《中药药理与临床》 CAS CSCD 北大核心 2020年第2期66-68,共3页 Pharmacology and Clinics of Chinese Materia Medica
基金 四川省科技厅课题项目(编号:2020YFS0012、2020YFS0013) 成都中医药大学“杏林学者”计划“新冠病毒应急专项”(编号:XGZX2003)。
关键词 新型冠状病毒肺炎 疫病 病因 治疗 预防 COVID-19 epidemic disease pathogenesis treatment prevent
  • 相关文献

参考文献12

二级参考文献28

共引文献1945

同被引文献276

引证文献21

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部